Results 161 to 170 of about 13,805 (198)
Some of the next articles are maybe not open access.
Treatment Planning for Molecular Targeted Radionuclide Therapy
Cancer Biotherapy and Radiopharmaceuticals, 2002Molecular targeted radionuclide therapy promises to expand the usefulness of radiation to successfully treat widespread cancer. The unique properties of radioactive tags make it possible to plan treatments by predicting the radiation absorbed dose to both tumors and normal organs, using a pre-treatment test dose of radiopharmaceutical.
Christine Hartmann, Siantar +3 more
openaire +2 more sources
Systemic targeted radionuclide therapy: Potential new areas
International Journal of Radiation Oncology*Biology*Physics, 2006Radiation oncology is entering an exciting new era with therapies being delivered in a targeted fashion through an increasing number of novel approaches. External beam radiotherapy now integrates functional and anatomic tumor imaging to guide delivery of conformal radiation to the tumor target.
openaire +2 more sources
Targeted Radionuclide Therapy of Prostate Cancer
2013Prostate cancer is an ideal target for the development of targeted radionuclide therapy because of the frequent occurrence of multi-focal disseminated disease when it recurs after treatment of disease initially thought to have been confined to the prostate gland or even at presentation in patients with advanced disease.
Stanley J. Goldsmith +5 more
openaire +1 more source
Monoclonal antibody targeted radionuclide therapy
2003Abstract The pivotal work by Kohler and Milstein (1) on the development of hybridoma technology has made the production of an unlimited supply of monoclonial antibody (mAb) molecules possible. A wide range of mAbs has been generated for applications in research and health care.
openaire +1 more source
Targeted radionuclide therapy for neuroendocrine tumours.
Endocrine-related cancer, 2003Evidence supporting the potential contribution of targeted radiotherapy to the management of neuroendocrine tumours is now strong. Acting systemically, this is an effective option for patients with inoperable or multi-site disease. Toxicity is generally low, being limited to reversible myelosuppression and theoretical nephrotoxicity.
openaire +2 more sources
Adverse Events in Targeted Radionuclide Therapy
RadioGraphicsTargeted radionuclide therapy is a rapidly growing field in the era of personalized medicine, and it is vital for physicians to recognize and appropriately manage therapy-related adverse events to deliver safe and effective patient care.
Kip E. Guja +7 more
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly